Our BI-SPR technology can provide high-quality data on kinetics, affinity, and specificity– all useful interaction characteristics in the drug discovery and development process. Because of their high sensitivity, small sample usage, and convenient label-free technique, our instruments have become increasingly powerful tools that provide information about various drug compounds and drug affinity. Protein and antibody-interaction studies are also used to investigate disease pathways and targets for potential drug therapies, and much more. Here at BI, our high-sensitivity instruments provide superior results for small-molecule detection, ensuring the best results possible for your drug development research.
